Sensys raises $31 million for clinical trial:
This article was originally published in Clinica
Blood sugar monitoring company Sensys Medical has closed a $31m financing round, which it will use to take it through a pivotal clinical trial in 2003 and into FDA panel hearings in early 2004. The Chandler, Arizona-based company was formerly known as Instrumentation Metrics.
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.